Efekti blokade COVID-19 na kontrolu glikemije i profil lipida kod pacijenata sa dijabetesom tipa 2: sistematski pregled i meta-analiza.
International journal of environmental research and public health
Sažetak istraživanja
Utjecaj izolacije COVID-19 na kontrolu glikemije i druge metaboličke parametre kod pacijenata s dijabetesom tipa 2 još uvijek se razvija.
Cilj Ovaj sistematski pregled i meta-analiza imaju za cilj da ispitaju efekte blokade COVID-19 na kontrolu glikemije i profil lipida kod pacijenata sa dijabetesom tipa 2.
Metode PRISMA okvir je bio metod koji se koristio za sprovođenje sistematskog pregleda i meta-analize, a strategija pretraživanja bila je zasnovana na modelu populacije, intervencije, kontrole i ishoda (PICO). Bazama podataka Health Sciences Research pristupilo se putem EBSCO-host-a, a EMBASE je pretraživao relevantne članke. Pretrage su vršene od početka baza podataka do 17. septembra 2021.
Rezultati Rezultati su identifikovali tri različite oblasti: kontrola glikemije, parametri lipida i indeks tjelesne mase. Utvrđeno je da je blokada COVID-19 dovela do značajnog broja (p n = 8417; pre-COVID gp, n = 8478). Meta-analiza glukoze u plazmi natašte (mg/dL) takođe je pokazala značajan (p n = 1159; gp pre COVID-a, n = 1168). Analiza indeksa tjelesne mase (BMI) (kg/m 2 ) također je pokazala da je gp nakon izolacije COVID-19 imao značajan (p n = 1186; gp prije COVID-a, n = 1177). Bilo je značajno ( p
Zaključak Nalazi sistematskog pregleda i meta-analize su pokazali da je blokada COVID-19 rezultirala značajnim povećanjem (p < 0,05) nivoa glikiranog hemoglobina, glukoze natašte i indeksa tjelesne mase kod pacijenata sa dijabetesom tipa 2. Nasuprot tome, učinak blokade uključujući i parametre ukupnog lipida, triglicerida i HDL holesterola, holesterol nije bio konzistentan.
Prikaži originalni naslov i sažetak na engleskom
The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
The impact of the COVID-19 lockdown on glycaemic control and other metabolic parameters in patients with type 2 diabetes is still evolving. Aim This systematic review and meta-analysis aims to examine the effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes.
Methods The PRISMA framework was the method used to conduct the systematic review and meta-analysis, and the search strategy was based on the population, intervention, control and outcome (PICO) model. The Health Sciences Research databases was accessed via EBSCO-host, and EMBASE were searched for relevant articles. Searches were conducted from inception of the databases until 17 September 2021.
Results The results identified three distinct areas: glycaemic control, lipid parameters and body mass index. It was found that COVID-19 lockdown led to a significant ( p n = 8417; pre-COVID gp, n = 8478). The meta-analysis of fasting plasma glucose (mg/dL) also showed a significant ( p n = 1159; pre-COVID gp, n = 1168). The body mass index (BMI) (kg/m 2 ) analysis also demonstrated that post-COVID-19 lockdown gp had a significantly ( p n = 1186; pre-COVID gp, n = 1177). There were significantly ( p
Conclusion The findings of the systematic review and meta-analysis have demonstrated that COVID-19 lockdown resulted in a significant increase ( p < 0.05) in the levels of glycated haemoglobin, fasting glucose and body mass index in patients with type 2 diabetes. In contrast, the effect of the lockdown on lipid parameters, including total cholesterol, triglycerides, LDL and HDL cholesterol was not consistent.
Izvorni podaci
- DOI
- 10.3390/ijerph19031095
- PMID
- 35162117
- PMCID
- PMC8834313
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom